NASDAQ:NVCN - Neovasc Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.02 0.00 (0.00 %) (As of 09/19/2018 08:00 AM ET)Previous Close$0.02Today's Range$0.02 - $0.0252-Week Range$0.02 - $1.89Volume24.32 million shsAverage Volume43.58 million shsMarket Capitalization$51.76 millionP/E Ratio-0.06Dividend YieldN/ABeta1.02 Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryFinancialsHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. Receive NVCN News and Ratings via Email Sign-up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical SymbolNASDAQ:NVCN CUSIPN/A Webwww.neovasc.com Phone604-270-4344 Debt Debt-to-Equity Ratio-4.96 Current Ratio3.41 Quick Ratio3.38 Price-To-Earnings Trailing P/E Ratio-0.06 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$5.39 million Price / Sales6.96 Cash FlowN/A Price / CashN/A Book Value($0.46) per share Price / Book-0.04 Profitability EPS (Most Recent Fiscal Year)($0.37) Net Income$-22,900,000.00 Net Margins-3,427.42% Return on EquityN/A Return on Assets-79.39% Miscellaneous Employees110 Outstanding Shares1,875,220,000Market Cap$51.76 million Neovasc (NASDAQ:NVCN) Frequently Asked Questions What is Neovasc's stock symbol? Neovasc trades on the NASDAQ under the ticker symbol "NVCN." When did Neovasc's stock split? How did Neovasc's stock split work? Neovasc shares reverse split on Monday, October 15th 2018. The 1-100 reverse split was announced on Tuesday, September 11th 2018. The number of shares owned by shareholders will be adjusted after the market closes on Friday, October 12th 2018. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 1 shares after the split. How were Neovasc's earnings last quarter? Neovasc Inc (NASDAQ:NVCN) announced its earnings results on Tuesday, March, 29th. The medical equipment provider reported ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.04. The medical equipment provider had revenue of $2.24 million for the quarter, compared to analyst estimates of $3.26 million. View Neovasc's Earnings History. When is Neovasc's next earnings date? Neovasc is scheduled to release their next quarterly earnings announcement on Tuesday, November, 13th 2018. View Earnings Estimates for Neovasc. What price target have analysts set for NVCN? 2 Wall Street analysts have issued twelve-month price objectives for Neovasc's shares. Their predictions range from $0.50 to $2.00. On average, they expect Neovasc's share price to reach $1.25 in the next twelve months. This suggests a possible upside of 6,150.0% from the stock's current price. View Analyst Price Targets for Neovasc. What is the consensus analysts' recommendation for Neovasc? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Neovasc. Are investors shorting Neovasc? Neovasc saw a drop in short interest in August. As of August 31st, there was short interest totalling 72,606,074 shares, a drop of 7.0% from the August 15th total of 78,084,367 shares. Based on an average daily trading volume, of 8,113,183 shares, the short-interest ratio is currently 8.9 days. View Neovasc's Current Options Chain. Who are some of Neovasc's key competitors? Some companies that are related to Neovasc include Invuity (IVTY), Endologix (ELGX), Apollo Endosurgery (APEN), RenovaCare (RCAR), Alphatec (ATEC), STRATA Skin Sciences (SSKN), Sensus Healthcare (SRTS), Motus GI (MOTS), Restoration Robotics (HAIR), Arch Therapeutics (ARTH), Invo Bioscience (IVOB), CAS Medical Systems (CASM), Repro-Med Systems (REPR), Obalon Therapeutics (OBLN) and iCAD (ICAD). Who are Neovasc's key executives? Neovasc's management team includes the folowing people: Mr. Fredericus A. Colen, Pres & CEO (Age 65)Mr. Christopher Clark BA (Honours), PgD, CA, CFO & Corp. Sec. (Age 46)Ms. Vicki Bebeau, VP of Clinical & Regulatory Affairs (Age 67)Mr. Randy Lane, VP of New Concept Devel. & Intellectual Property (Age 45)Mr. Alexei J. Marko, Advisor & Director (Age 49) Has Neovasc been receiving favorable news coverage? News headlines about NVCN stock have trended somewhat positive on Wednesday, Accern Sentiment reports. Accern identifies positive and negative press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Neovasc earned a news and rumor sentiment score of 0.18 on Accern's scale. They also assigned media coverage about the medical equipment provider an impact score of 46.57 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term. View Recent Headlines for Neovasc. Who are Neovasc's major shareholders? Neovasc's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (2.87%), Gagnon Advisors LLC (2.45%) and Gagnon Securities LLC (1.02%). Which major investors are buying Neovasc stock? NVCN stock was purchased by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Gagnon Advisors LLC and Gagnon Securities LLC. How do I buy shares of Neovasc? Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Neovasc's stock price today? One share of NVCN stock can currently be purchased for approximately $0.02. How big of a company is Neovasc? Neovasc has a market capitalization of $51.76 million and generates $5.39 million in revenue each year. The medical equipment provider earns $-22,900,000.00 in net income (profit) each year or ($0.37) on an earnings per share basis. Neovasc employs 110 workers across the globe. How can I contact Neovasc? Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, Richmond A1, V6V 2J7. The medical equipment provider can be reached via phone at 604-270-4344 or via email at [email protected] MarketBeat Community Rating for Neovasc (NASDAQ NVCN)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 246 (Vote Outperform)Underperform Votes: 206 (Vote Underperform)Total Votes: 452MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVCN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVCN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/19/2018 by MarketBeat.com StaffFeatured Article: Do Tariffs Work?